M&A

M&A

RPG Active Pharma acquires API business of Raghava Life Sciences for Rs.135-Cr

BSE Announcement   Business Line   RPG Active Pharma  

Mumbai-based RPG Active Pharma , a wholly-owned subsidiary of RPG Life Sciences, is to acquire the API and intermediates business of Hyderabad-based Raghava Life Sciences on a going-concern basis through a slump sale. The transaction is valued at INR 135 crore. The acquisition will be financed through the equity raise recently announced by the company. Quillan Partners served as legal advisor, o3 Capital as financial advisor, and Deloitte as the financial due diligence partner to the transaction.Raghava Life Sciences operates a manufacturing facility spanning approximately 9 acres with an installed capacity of 300 KL. It maintains a research setup and holds WHO-GMP and EU-GMP certifications. In fiscal year 2026, the business recorded revenues of approximately INR 19 crore.